Clinical Trial Update: Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the mechanism of action of Travatan 0.004% in people with glaucoma or ocular hypertension. The study status is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Travatan (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED